Bausch + Lomb Names Thomas J. Appio Interim CEO Following Brent Saunders' Departure

Bausch + Lomb Corporation announced that Thomas J. Appio, chairman of its board and CEO of parent company Bausch Health, has been appointed interim CEO effective immediately. This follows the mutual agreement for Brent Saunders to depart his role as CEO, a position he held since 2023; no reason for the departure was disclosed. Appio will continue serving as Bausch Health CEO while leading Bausch + Lomb. The board cited Appio’s deep business knowledge and global leadership experience as key factors in the appointment. Separately, based on preliminary third-quarter results, both companies expect to raise full-year 2026 adjusted EBITDA guidance excluding Acquired IPR&D. Detailed financial results are scheduled for release on October 28, 2026, following the current blackout period.